The use of vildagliptin has been approvedin Indian patients for the treatment of T2DM as monotherapy or in combination with metformin, sulfonylureas, and thiazolidinediones, as well as with insulin [20].In India, vildagliptin and metformin combination tablets are available in 50/500 mg, 50/850 mg, and 50/1000 mg doses [20]. Here, INS is linked to type 2 diabetes mellitus.